Salesforce

Measure Paper - CMS 2022 Measure 144v10 for NextGen Office

Printable View
« Go Back

Information

 
Application Version
Program/Measure YearMIPS 2022
Build Version
Document Summary
DomainEffective Clinical Care
Measure NameHeart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)
DescriptionPercentage of patients aged 18 years and older with a diagnosis of heart failure (HF) with a current or prior left ventricular ejection fraction (LVEF) < 40% who were prescribed beta-blocker therapy either within a 12-month period when seen in the outpatient setting OR at each hospital discharge.
Attachment 1
Attachment 2
Attachment 3
Attachment 4
Attachment 5
KeywordseCQM MIPS CMS144 "heart failure" HF "beta-blocker therapy" "left ventricular systolic dysfunction" LVSD "beta blockers" drugs medications
TitleMeasure Paper - CMS 2022 Measure 144v10 for NextGen Office
URL NameMeasure-Paper-CMS-2022-Measure-144v10-for-NextGen-Office
Powered by